Simplified screening in an emergency department detected methicillin-resistant Staphylococcus aureus by Mogensen, Christian Backer et al.
Syddansk Universitet
Simplified screening in an emergency department detected methicillin-resistant
Staphylococcus aureus






Publisher's PDF, also known as Version of record
Document license
CC BY-NC
Citation for pulished version (APA):
Mogensen, C. B., Kjældgaard, P., Jensen, C., & Chen, M. (2016). Simplified screening in an emergency
department detected methicillin-resistant Staphylococcus aureus. Danish Medical Journal, 63(2), [A5195].
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 13. aug.. 2017
Dan Med J 63/2  February 2016 da n i s h m E d i c a l J O U R n a l   1
abstRact
IntroductIon: All patients admitted to Danish hospitals 
are screened for methicillin-resistant Staphylococcus aureus 
(MRSA) by a questionnaire consisting of 19 questions issued 
by the Danish Health and Medicines Authority (DHMA). This 
study aimed to evaluate which of the questions were most 
useful. Furthermore, we assessed if other questions were 
more adequate and if a simplified screening model would 
perform equal to or better than the one presently used. 
Methods: Swabs were obtained for MRSA culture from pa-
tients who were more than ten years old and who had been 
admitted to an emergency department (ED). All DHMA 
questions together with a range of additional questions 
were answered. 
results: Among the 1,220 patients who participated, 0.9% 
were MRSA carriers. Only three DHMA questions were as-
sociated with a significant risk of MRSA carriage. The add-
itional questions associated with MRSA were “stayed with a 
non-Danish family within the past three years” and “daily 
contact with children at a nursery or kindergarten”. A new 
model with only five questions increased the sensitivity in-
significantly from 18-55% to 73% in the revised model, 
whereas no changes were seen for specificity, predictive 
values or likelihood ratios. 
conclusIons: The DHMA’s targeted screening for MRSA 
detection contained only few questions with significant as-
sociation to MRSA carrier stage. A model based on only five 
questions seems to insignificantly improve the MRSA 
screening in this population. In order to develop a more 
simple and effective screening model, we recommend that 
our findings be tested in another ED patient population. 
FundIng: Southern Jutland Hospital funded this study. 
trIal regIstratIon: not relevant.
The burden of methicillin-resistant Staphylococcus au-
reus (MRSA) varies between countries. In Denmark, the 
prevalence has increased in the past decade [1]. New 
MRSA strains have been identified which are associated 
with pig farming [2], but many other strains have been 
isolated as well, suggesting that there are multiple 
sources of community-acquired MRSA [3].
Since the majority of patients who are admitted to 
hospital pass through the emergency departments (ED), 
the EDs play a crucial role in early identification of MRSA 
carriers. All patients admitted to Danish hospitals are 
screened for exposure to MRSA by a questionnaire 
 issued by the Danish Health and Medicines Authority 
(DHMA) [4]. The questionnaire consists of a mandatory 
section to be used for all admissions with four main 
questions and five sub-questions addressing common 
risk situations, a section used in special risk situations 
(five questions) and five individual risk factors; a total of 
19 variables are to be checked if the full screening pro-
cedure is followed. The procedure is quite complex, it 
requires some instruction and is time-consuming.
In a recent ED study, we used this questionnaire ap-
proach and found a 0.9% MRSA prevalence, and we 
were able to identify 18-27% of the MRSA carriers if the 
mandatory general risk questions were answered, and 
up to 55% of the MRSA carriers if all the general risk, 
specific risk and individual risk questions were an-
swered. Only 9% of the MRSA carriers would be isolated 
using the DHMA isolation recommendations. The ED 
study also revealed that the majority of MRSA clones 
originated from pigs and Northern Germany, which re-
flects the fact that the ED was situated only 25 km from 
the Danish-German in a rural area with several pig farms 
[5].
The DHMA screening questionnaire was based on 
the knowledge of an established range of known risk 
factors for MRSA acquisition, such as contacts to local 
outbreaks or other MRSA carriers, travelling and non-
Danish origin, or skin diseases [6, 7]. Acknowledging that 
the majority of MRSA cases in our study derived from 
pigs and  Northern Germany, we hypothesised that a mi-
nor part of the DHMA questions together with other ad-
ditional questions more targeted to these risk factors  
for MRSA would detect the MRSA carriers to the same 
or at a higher extent than the currently used DHMA 
screening.
The aim of the present study was: first, to evaluate 
which of the 19 questions in the DHMA screening were 
most useful for detecting MRSA; second, to analyse if 
other questions regarding MRSA exposure would per-
form better than the ones currently included in the 
screening; and third, if a more simplified screening  
model combining the most accurate questions for detec-
tion of MRSA risk would perform equally to or better 
than the presently used DHMA MRSA screening in this 
area of Denmark.
simplified screening in an emergency department 
detected methicillin-resistant staphylococcus aureus











Dan Med J  
2016;63(2):A5195
 2  da n i s h m E d i c a l J O U R n a l Dan Med J 63/2  February 2016
mEthOds
The method has been described in details elsewhere [5]. 
In brief, all patients aged ten years or more, who were 
admitted to the ED, were invited to participate in the 
study. If they accepted, a nasal and pharyngeal swap 
was obtained for MRSA culture. At the same time, the 
patients were invited to answer all the DHMA questions 
concerning general and specific risk situations and indi-
vidual risk factors for MRSA exposure. Furthermore, in 
the search for other questions concerning MRSA expos-
ure, the patients were asked a range of additional ques-
tions, based on a literature search, local experience and 
specialist considerations (table 1).
The nurse who cared for the patient asked all the 
questions immediately after the patient’s arrival and re-
corded the answers in a structured electronic question-
naire which transferred the answers to a secure data en-
vironment. The results from the questionnaires were 
linked to the results from the MRSA cultures and ana-
lysed in Stata 13. Odds ratios (OR) and 95% confidence 
interval were calculated for each question using univari-
ate logistic regression. A screening model was suggested 
using a combination of the questions that had a signifi-
cant association with MRSA.
The study was registered with the Danish Data Pro-
tection Agency (number 2008-58-0035) and ethical clear-
ance was obtained from the regional ethical committee 
(mail 2 September 2013), which considered the study to 
be a quality assurance study. Only patients who freely 
consented to participate were included in the study.
Trial registration: not relevant.
REsUlts
Among 1,945 admitted patients, 1,220 consented (73% 
of all invited) to participate in the study. A total of 11 pa-
tients (0.9%) were found to be MRSA carriers.
table 2 shows the OR for the currently used DHMA 
questions. The questions concerning previous MRSA, 
contact with living pigs and daily stay in an assisted living 
facility were all associated with a significantly increased 
risk of MRSA carriage, but the remaining DHMA ques-
tions were not. For the following risk indicators, no 
MRSA patients were identified: “treatment outside 
Nordic countries within the past six months”, “worked at 
hospitals with MRSA outbreaks within the past six 
months”, “worked at hospitals or similar institutions 
outside the Nordic countries within the past six 
months”, “worked at Nordic hospital with MRSA out-
tablE 1
Questions tested for usefulness as risk markers for methicillin-resistant 
Staphylococcus aureus.
Origin
Which country are you from?
Which country are your parents from?
Contacts to children
Do you have daily close contact with children:
Who are adopted from a non-Nordic country within  
 the past 6 months?
Who are at a day care or kindergarten?
Antibiotics
Have you been treated with antibiotics the past 2 years?
If yes, which kind of infection was treated?
Relation to Germany
Do you live in Germany?
Does anyone in your household work in Germany?
Does anyone in your household work at a German hospital?
Relation to farms
Do you live less than 500 m from a farm?
Do you visit a farm more than once a month?
Does anyone from your household visit a farm more  
 than once a week?
Living place
Do you receive home care?
Have you been living in a nursing home within the past 6 months?
Have you been admitted to hospital within the past 6 months?
Have you been living with a foreign family within the past 3 years?
Have you been living in a boarding school within the past 3 years?
Have you been in prison within the past 6 months?
Have you been in the military/civil defence within the past 6 months?
Foreign countries apart from Germany
Have you stayed outside of Denmark for more than 3 days in the  
 past 3 years?
 If yes, in which countries?
Patients with high suspicion of methicillin-resistant Staphylococcus au-
reus colonisation require isolation, but are difficult to identify.
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break within the past six months”, “stayed in poor sani-
tary facilities (refugee camps, war zones) or asylum cen-
tre within the past six months”, “household contacts to 
persons living outside the Nordic countries”, “signs of or 
exposure to MRSA in foreign countries”, “recurrent skin 
abscesses” and “intravenous drug abuse”.
table 3 shows the analysis of the examined alterna-
tive questions for detection of MRSA carriage. A signifi-
cant association with MRSA was found for the questions 
“stayed with a non-Danish family within the past three 
years”, “daily contact with children at a nursery or kin-
dergarten” and “imprisoned within the past six months”. 
An association with MRSA was shown for no questions 
concerning relation to pig farming, antibiotic treatment, 
adoptions, living with people working in Germany or at 
nursing home, being a soldier, staying outside of Europe 
and relation to other countries or institutions apart from 
the above-mentioned.
Since the number of patients with MRSA was low, 
we were unable to identify screening questions associ-
ated with MRSA at the multivariate level. However, we 
selected those DHMA questions and alternative ques-
tions that had the highest significant OR in order to be 
able to present a revised model for identification of 
MRSA. The following five questions were included: “Any 
information concerning previous MRSA”, “contacts with 
living pigs within the past six months”, “daily stay in an 
assisted living facility”, “daily contact with children at a 
nursery or kindergarten” or “stayed with non-Danish 
family within the past three years”. We did not include 
imprisonment despite a high OR for MRSA, since the to-
tal number of patients with this exposure was very low.
If any of these five questions indicated exposure to 
MRSA, the screening test was positive. The screening 
measures were calculated and compared with the basic 
DHMA screening model where only the four mandatory 
questions for all patients were included, and also with 
the full DHMA model in which all the 19 questions in-
cluding those relating to special risk situations and  
individual risk factors were included. The results are re-
ported in table 4. The new model increased the sensi-
tivity insignificantly from 18-55% in the DHMA models to 
73% in the revised model, while no major changes were 
seen in the specificity, predictive values or likelihood  
ratios.
discUssiOn
We found that among the 19 DHMA questions, only 
three questions were associated with an increased risk 
of MRSA carriage: “previous MRSA”, “daily contact with 
living pigs” and “daily stay in assisted living facilities”. In 
a range of alternative questions designed to detect 
MRSA, only “staying with a non-Danish family within the 
past three years”, “daily contact with children at a nur-
sery or kindergarten” and “imprisonment within the 
past six months” were associated with an increased risk 
of MRSA. Combining five of these questions into a new 
screening model did improve, though insignificantly so, 
the MRSA detection rate compared with the currently 
used DHMA screening model, yielding a sensitivity in-
crease from 18-55% to 73%.
Other studies from EDs concerning risk factors have 
recently been published. In Northern Germany, the com-
tablE 2
Danish Health and Medicines Authority risk situations and individual risk factors for methicillin-resistant 
Staphylococcus aureus carriage.
no mRsa mRsa




No 1,157 (99) 9 (1) 1
Yes      39 (95) 2 (5) 6.6 (1.4-32)
MRSA-free after previous MRSA?
Yes 16 (94) 1 (6) 1
No 23 (96) 1 (4) 0.7 (0.04-12)
MRSA contacts within the past 6 months?
No 1,176 (99) 10 (1) 1
Yes       20 (95)   1 (5) 5.8 (0.7-48)
Long-term MRSA contacts if MRSA contacts 
within the past 6 months?
No 15 (100) 0 (0) NC
Yes   4 (80) 1 (20)
Contacts with living pigs within the past 6 months?
No 1,139 (99) 8 (1) 1
Yes      53 (95) 3 (5) 8.1 (2.0-31)
Daily contact with pigs if contact within 
the past 6 months?
No 28 (93) 2 (7) 1
Yes 24 (96) 1 (4) 0.8 (0.2-2.7)
Special risk situations within past 6 months
Daily stay in assisted living facility?
No 1,199 (99) 10 (1) 1
Yes      10 (91)   1 (9) 12 (1.2-103)
Individual risk factors
Wounds?
No 1,110 (99) 10 (1) 1
Yes      99 (99)   1 (1) 1.1 (0.1-8.9)
Abscesses?
No 1,154 (99) 10 (1) 1
Yes      55 (98)   1 (2) 2.1 (0.3-17)
Chronic respiratory tract infections 
(including sinusitis and obstructive lung disease)?
No 1,084 (99) 10 (1) 1
Yes    125 (99)   1 (1) 0.9 (0.1-6.8)
Indwelling catheters or tubes?
No 1,081 (99) 10 (1) 1
Yes    128 (99)   1 (1) 0.8 (0.1-6.6)
CI = confidence interval; MRSA = methicillin-resistant Staphylococcus aureus; NC = not calculated; OR 
= odds ratio. 
mRsa status, n (%)
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tablE 3






Relation to other countries
Danish citizen?
Yes 1,114 (99) 10 (1) 1
No      48 (98)   1 (2) 2.3 (0.3-19)
Parents from Denmark?
Yes 1,059 (99) 9 (1) 1
No    101 (98) 2 (2) 2.3 (0.5-11)
Household contacts working in Germany?
No 1,168 (99) 10 (1) 1
Yes      41 (98)   1 (2) 2.8 (0.4-23)
Stayed for more than 3 days outside Denmark within the past 3 years?
No 603 (99.5) 3 (0.5) 1
Yes 606 (99) 8 (1) 2.6 (0.7-10)
Stayed for more than 3 days in Germany within the past 3 years?
No 943 (99) 8 (1) 1
Yes 266 (99) 3 (1) 1.3 (0.4-5)
Stayed for more than 3 days in other European countries (excluding the  
Nordic countries)?
No 793 (99.4) 5 (0.6) 1
Yes 416 (99) 6 (1) 2.3 (0.7-7.5)
Stayed with a non-Danish family within the last 3 years?
No 1,012 (99) 6 (1) 1
Yes    197 (97) 5 (3) 4.3 (1.3-14)
Relation to institutions
Daily contact with children at nursery or kindergarten?
No 1,044 (99) 6 (1) 1
Yes     165 (97) 5 (3) 5.3 (1.6-17)
Local authority home help?
No 1,034 (99) 9 (1) 1
Yes     175 (99) 2 (1) 1.3 (0.3-6)
Admitted to hospital within the past 6 months?
No 806 (99) 7 (1) 1
Yes 403 (99) 4 (1) 1.1 (0.3-3.9)
Living at a boarding school?
No 1,189 (99) 10 (1) 1
Yes      20 (95)   1 (5) 5.9 (0.7-47)
Imprisoned within the past 6 months?
No 1,202 (99) 10 (1) 1
Yes        7 (88)   1 (13) 17 (1.9-52)
Relation to farming and antibiotics
Living less than 500 m from pig farm?
No 883 (99) 9 (1) 1
Yes 326 (99) 2 (1) 0.6 (0.1-2.8)
Visiting a pig farm more than once a month?
No 1,054 (99) 8 (1) 1
Yes    155 (98) 3 (2) 2.6 (0.7-9.7)
Household member visits pig farms more than once a week?
No 1,093 (99) 10 (1) 1
Yes    116 (99)   1 (1) 0.9 (0.1-7.4)
Received antibiotic treatment within the past 2 years?
No 428 (99) 5 (1) 1
Yes 624 (99) 6 ( 1) 0.8 (0.2-2.7)
CI = confidence interval; MRSA = methicillin-resistant Staphylococcus aureus; OR = odds ratio.
mRsa status, n (%)
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munity carriage was 1.3% and male sex and allergies 
were associated [8]. In Saarland, Germany, the preva-
lence on admission was 2.2%; and former MRSA, skin 
conditions and indwelling catheters were risk factors [9]. 
In Sweden, being born in a foreign country, receiving 
healthcare abroad and foreign travel were strongly asso-
ciated with MRSA [10]. In Belgium, known MRSA history 
and stay in a care facility were associated with MRSA, 
and more than 90% of MRSA belonged to five health-
care-associated strains [11]. In Scotland, a 2% MRSA 
prevalence in ED was associated with the number of ad-
missions, specialty of admission, age, and hospital or 
care home [12]. This wide geographical variation in risk 
factors reflects the heterogeneity of the MRSA problem 
and makes it difficult to extrapolate knowledge about 
risk factors from one country to another.
Other countries have experienced similar difficulties 
in detecting MRSA by targeted screening as those ascer-
tained in the present study. In London, where the MRSA 
prevalence is around 2%, the previous target policy 
would have detected 55% of MRSA cases upon admis-
sion [13], in Scotland 50-53% [14], and in Switzerland 
22% [15] by using question-based targeted MRSA 
screening strategies; all of these are quite similar to our 
results.
Our findings have clinical implications. The clinical 
importance of not isolating a majority of MRSA carriers, 
while other patients are isolated unnecessarily, has been 
discussed elsewhere [5].The study suggests that the 
rather comprehensive DHMA screening model with 19 
variables may be simplified to a five-questions model 
and still maintain the same or a higher sensitivity. This is 
in accordance with more simple, targeted strategies 
used in other countries [14-16].
The study also reveals that it may be difficult to de-
velop a highly accurate question-based, targeted screen-
ing model for MRSA. Further development of targeted 
MRSA screening is difficult and requires large patient 
groups since the occurrence of MRSA carriage is low 
among the admitted patients. Furthermore, since the 
prevalence of MRSA in any ED depends on the popula-
tion exposure to MRSA, e.g. contact to pig farms and 
other countries, the value of an MRSA screening ques-
tionnaire varies from one area to another, and it may 
not apply to an entire nation.
Controversy exists as to whether universal screen-
ing, which is costly but simple and may detect more 
MRSA carriers, should replace exposure-based targeted 
screening, which might be both complex, time-consum-
ing and may lead to missed carriers [14]. In England, uni-
versal screening has replaced targeted screening [13], 
but the strategy is challenged by studies finding that a 
screening strategy based on clinical risk is more prag-
matic and more cost-effective [17]. In Scotland, targeted 
screening for patients based on three questions  
achie ved detection rates of 50-53%, similar to universal 
screening, and targeted screening has now been imple-
mented [14]. In Ireland, evaluation of universal versus 
targeted MRSA screening strategies concluded that tar-
geted screening of at-risk patients on admission remains 
the most efficient strategy for early identification of 
MRSA-positive patients, and only few additional patients 
would be identified using a universal screening approach 
[18].
In Denmark, where the prevalence of MRSA re-
mains low, the in-hospital transmission of community-
acquired MRSA is nine times lower than hospital-ac-
quired MRSA [19]. Rather than aiming at a general MRSA 
screening at hospital level, this finding encourages con-
tinued use of targeted screening and it emphasises the 
importance of standard precautions for the prevention 
of MRSA transmission, which has been shown to signifi-
cantly reduce in-hospital MRSA transmission [15, 20].
The present study has some limitations. Despite a 
three-month inclusion period, only 11 MRSA patients 
were identified, which precluded multivariate analyses 
and resulted in inability to prove a better performance 
of a new screening model based on fewer questions 
than the currently used DHMA screening. Furthermore, 
since the new model for detection of MRSA was devel-
oped in the present study population, another popula-
tion is required to evaluate the reproducibility of the re-
sults. Finally, the study group only represents two thirds 
tablE 4
Comparison of the Danish Health and Medicines Authority s’ model and an alternative screening model 
for methicillin resistant Staphylococcus aureus.
basic dhma  
model,  
4 questions







Screening question positive      76    507    390
True MRSA      11      11      11
True positive        2        6        8
True negative 1,135    708    827
False positive      74    501    382
False negative        9        5        3
Total 1,220 1,220 1,220
Screening values
Sensitivity, median (95% CI) 18 (2-52) 55 (23-83) 73 (39-94)
Specificity, median (95% CI) 94 (92-95) 59 (56-61) 68 (67-71)
Positive predictive value, median (95% CI)    3 (0-9)   1 (0-2)   2 (0-4)
Negative predictive value, median (95% CI) 99 (98-100) 99 (98-100) 99 (99-100)
Likelihood ratios 
Likelihood ratio of positive test, median (95% CI) 3.0 (0.8-11) 1.3 (0.8-2.3) 2.3 (1.6-3.3)
Likelihood ratio of negative test, median (95% CI) 0.9 (0.7-1.2) 0.8 (0.4-1.5) 0.4 (0.1-1.05)
CI = confidence interval; DHMA = Danish Health and Medicines Authority; MRSA = methicillin-resistant 
Staphylococcus aureus.
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of all the admitted patients, which in some respects dif-
fered from the non-participating patients; and this might 
have affected the validity of the results. This aspect has 
been  discussed elsewhere [5].
cOnclUsiOns
We found that the DHMA-targeted screening for MRSA 
detection contained only few questions with a signifi-
cant association with MRSA carrier stage. A model based 
on only five questions seems to improve, though not sig-
nificantly so, the MRSA screening in this population. In 
order to develop a simple and more effective screening 
model, we recommend that our findings be tested in an-
other ED patient population.
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